Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00296-021-04809-3 http://scihub22266oqcxt.onion/10.1007/s00296-021-04809-3 33611657!7897416!33611657     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33611657&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Rheumatol+Int 2021 ; 41 (4): 811-817 Nephropedia Template TP {{tp|p=33611657|t=2021. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review |pdf=|usr=}}{{33611657}} gab.com Text COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review JO: Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33611657 #FOAvip Coronavirus disease 2019 (COVID-19) refers to the clinical picture of an important and severe infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the current knowledge on the pathophysiology and clinical manifestations of COVID-19, it is safe to state that both COVID-19 and inflammatory rheumatic disorders cause a cytokine storm and merit treatment with anti-rheumatic drugs. Three patients, who were on regular follow-up due to the diagnosis of familial Mediterranean fever (FMF), contracted COVID-19 infection; and their pre-clinical and post-clinical data as well as laboratory, prognosis and treatment data were investigated. Effects of colchicine in FMF patients who contracted COVID-19 infection were presented in this study. All the cases recovered from COVID-19 without complications. The present study suggests that colchicine can positively affect the prognosis of COVID-19 in FMF patients; therefore, experience of rheumatologists in the use of anti-inflammatory drugs can be highly instrumental in management of COVID-19 patients. Twit Text FOAVip COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review ????Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33611657 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33611657 #FOAvip English Wikipedia <ref>{{Cite pmid|33611657}}</ref> COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review #MMPMID33611657 Nas K; Eryilmaz N; Geyik MF; Altas A Rheumatol Int 2021[Apr]; 41 (4): 811-817 PMID33611657show ga Coronavirus disease 2019 (COVID-19) refers to the clinical picture of an important and severe infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the current knowledge on the pathophysiology and clinical manifestations of COVID-19, it is safe to state that both COVID-19 and inflammatory rheumatic disorders cause a cytokine storm and merit treatment with anti-rheumatic drugs. Three patients, who were on regular follow-up due to the diagnosis of familial Mediterranean fever (FMF), contracted COVID-19 infection; and their pre-clinical and post-clinical data as well as laboratory, prognosis and treatment data were investigated. Effects of colchicine in FMF patients who contracted COVID-19 infection were presented in this study. All the cases recovered from COVID-19 without complications. The present study suggests that colchicine can positively affect the prognosis of COVID-19 in FMF patients; therefore, experience of rheumatologists in the use of anti-inflammatory drugs can be highly instrumental in management of COVID-19 patients. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2[MESH] |Adult[MESH] |Aged[MESH] |COVID-19/immunology[MESH] |Colchicine/*therapeutic use[MESH] |Familial Mediterranean Fever/*drug therapy[MESH] |Female[MESH] |Humans[MESH] |Interleukin-1/antagonists & inhibitors[MESH] |Male[MESH] |Middle Aged[MESH]COVID-19 in patients with familial Mediterranean fever treated with co(epmc).pdf DeepDyve Pubget Overpricing